Embarc

Inkstone Feibo Acquisition Corp

CIK: 1930857

SPAC Overview

$60M
IPO Size
Withdrawn
Current Status

Timeline Progress

About

Inkstone Feibo Acquisition Corp. is a blank-check company formed to pursue an initial business combination. Its stated focus is biotechnology and green technology opportunities emphasizing ESG practices in the United States and Taiwan.

Investment Focus

Biopharmaceuticals, Renewable Energy

Geographic Focus

United States, Taiwan

Embarc dashboard

What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.

  • Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
  • Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
  • The full 8-K lifecycle timeline, each event linked to its filing
  • Price history across the unit, share and warrant tickers
  • Follow it, and see it change on your watchlist
Open in the dashboard

SPAC Team

Sponsors

Inkstone Feibo Sponsor

Leadership

I-Fa Chang
Chairman of the Board of Directors, Chief Executive Officer
Xuedong Tian
Chief Financial Officer, Director
Hanzhong Li
Director Nominee
Kevin D. Vassily
Director Nominee
Teng-Wei Chen
Director Nominee

Extended Team Information

The team brings technology-focused investment, advisory and capital-markets experience, biotechnology operating and investment experience, and experience in ESG and green/environmental technology.

Key Information

State of Incorporation
DE
SIC
6770
SPAC Ticker
N/A

External Resources

SEC Filings
View Detailed Analysis